Lidocain Accord

Lidocaine Hydrochloride, the active ingredient in Lidocain Accord, is a local anesthetic presented as a sterile injectable solution for epidural, intramuscular and intravenous use. It provides reversible nerve block to facilitate minor surgical procedures, epidural analgesia and intravenous regional anesthesia in adult patients. The formulation is intended for use under the supervision of qualified healthcare professionals.

GNH USA supplies Lidocain Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and surgical centres worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution.

Lidocain Accord, a local anesthetic, is used to achieve temporary loss of sensation in specific clinical settings.

- Minor surgical procedures: provides local anesthesia to facilitate incision and manipulation without pain. - Epidural analgesia: produces segmental nerve block for pain relief during labor or postoperative period. - Intravenous regional anesthesia (Bier block): induces reversible anesthesia of a limb for short surgical interventions.

Adverse reactions to Lidocain Accord may vary from mild, transient events to rare serious complications.

Common Side Effects: - Transient tingling or numbness at the injection site. - Mild dizziness or light‑headedness. - Nausea. - Metallic taste.

Serious or Rare Side Effects: - Cardiac arrhythmias or conduction block. - Seizures due to central nervous system toxicity. - Severe allergic reactions such as anaphylaxis.

When using Lidocain Accord, consider the following precautions to ensure patient safety.

- Dose adjustment: reduce doses in patients with hepatic impairment. - Monitoring: observe cardiovascular and CNS status during high‑dose or rapid administration. - Allergy: avoid in individuals with known hypersensitivity to amide‑type local anesthetics. - Pregnancy: use only if the benefit outweighs the risk, as safety data are limited. - Drug interactions: review concomitant use of class I antiarrhythmics and CNS depressants. - Store at ambient temperature: keep below 25 °C, protect from moisture and light, retain in the original container.

Lidocain Accord may interact with other medicines; awareness of major and moderate interactions helps mitigate risk.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may increase risk of cardiotoxicity. - CNS depressants (e.g., benzodiazepines, opioids): may potentiate central toxicity. - Beta‑blockers: can enhance bradycardia when combined with high doses.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase bleeding risk with regional techniques. - Diuretics: may alter plasma protein binding, affecting lidocaine levels. - Magnesium sulfate: can potentiate neuromuscular blockade.